APO RESEARCH · REPORT
Self Injection Device
The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
Product & engineering
Understand the product.
The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
An auto-injector is a medical device designed to deliver a dose of a particular drug.
Selected research
Industry Growth & Trends
Global Self Injection Device Industry Growth and Trends Forecast to 2032
Market perspective
The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
An auto-injector is a medical device designed to deliver a dose of a particular drug.
Market competition is not intense. Novo Nordisk, Mylan, Pfizer, Sanofi, BD, Eli Lilly and Gerresheimer, etc. are the leaders of the industry, with about 60% market shares.
Read the full market overview
Europe is the largest consumption place, with a consumption market share nearly 42%. Following Europe, North America is the second largest consumption place with the consumption market share of 31%.
Report Scope
This report provides a structured, data-driven view of the global Self Injection Device market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Self Injection Device market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Self Injection Device market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Self Injection Device.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Self Injection Device market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Self Injection Device Market by Company
Novo Nordisk
Mylan
Pfizer
Sanofi
BD
Eli Lilly
Gerresheimer
Dongbao
Ypsomed
Owen Mumford
Antares Pharma
Haselmeier
Self Injection Device Segment by Type
Reusable Self Injection Device
Disposable Self Injection Device
Self Injection Device Segment by Application
Insulin Injection
Epinephrine Injection
Others
Self Injection Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Self Injection Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Self Injection Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Self Injection Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Self Injection Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Self Injection Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Reusable Self Injection Device
- Disposable Self Injection Device
Applications
- Insulin Injection
- Epinephrine Injection
- Others
Companies covered
- Novo Nordisk
- Mylan
- Pfizer
- Sanofi
- BD
- Eli Lilly
- Gerresheimer
- Dongbao
- Ypsomed
- Owen Mumford
- Antares Pharma
- Haselmeier
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Self Injection Device Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Self Injection Device Sales Estimates and Forecasts (2021-2032)
- 1.3 Self Injection Device Market by Type
- 1.3.1 Reusable Self Injection Device
- 1.3.2 Disposable Self Injection Device
- 1.4 Global Self Injection Device Market Size by Type
- 1.4.1 Global Self Injection Device Market Size Overview by Type (2021-2032)
- 1.4.2 Global Self Injection Device Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Self Injection Device Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Self Injection Device Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Self Injection Device Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Self Injection Device Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Self Injection Device Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Self Injection Device Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Self Injection Device Industry Trends
- 2.2 Self Injection Device Industry Drivers
- 2.3 Self Injection Device Industry Opportunities and Challenges
- 2.4 Self Injection Device Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Self Injection Device Revenue (2021-2026)
- 3.2 Global Top Players by Self Injection Device Sales (2021-2026)
- 3.3 Global Top Players by Self Injection Device Price (2021-2026)
- 3.4 Global Self Injection Device Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Self Injection Device Major Company Production Sites & Headquarters
- 3.6 Global Self Injection Device Company, Product Type & Application
- 3.7 Global Self Injection Device Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Self Injection Device Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Self Injection Device Players Market Share by Revenue in 2025
- 3.8.3 2025 Self Injection Device Tier 1, Tier 2, and Tier 3
4 Self Injection Device Regional Status and Outlook
- 4.1 Global Self Injection Device Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Self Injection Device Historic Market Size by Region
- 4.2.1 Global Self Injection Device Sales in Volume by Region (2021-2026)
- 4.2.2 Global Self Injection Device Sales in Value by Region (2021-2026)
- 4.2.3 Global Self Injection Device Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Self Injection Device Forecasted Market Size by Region
- 4.3.1 Global Self Injection Device Sales in Volume by Region (2027-2032)
- 4.3.2 Global Self Injection Device Sales in Value by Region (2027-2032)
- 4.3.3 Global Self Injection Device Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Self Injection Device by Application
- 5.1 Self Injection Device Market by Application
- 5.1.1 Insulin Injection
- 5.1.2 Epinephrine Injection
- 5.1.3 Others
- 5.2 Global Self Injection Device Market Size by Application
- 5.2.1 Global Self Injection Device Market Size Overview by Application (2021-2032)
- 5.2.2 Global Self Injection Device Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Self Injection Device Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Self Injection Device Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Self Injection Device Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Self Injection Device Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Self Injection Device Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Self Injection Device Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Novo Nordisk
- 6.1.1 Novo Nordisk Company Information
- 6.1.2 Novo Nordisk Business Overview
- 6.1.3 Novo Nordisk Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Novo Nordisk Self Injection Device Product Portfolio
- 6.1.5 Novo Nordisk Recent Developments
- 6.2 Mylan
- 6.2.1 Mylan Company Information
- 6.2.2 Mylan Business Overview
- 6.2.3 Mylan Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Mylan Self Injection Device Product Portfolio
- 6.2.5 Mylan Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Pfizer Self Injection Device Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 Sanofi
- 6.4.1 Sanofi Company Information
- 6.4.2 Sanofi Business Overview
- 6.4.3 Sanofi Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sanofi Self Injection Device Product Portfolio
- 6.4.5 Sanofi Recent Developments
- 6.5 BD
- 6.5.1 BD Company Information
- 6.5.2 BD Business Overview
- 6.5.3 BD Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 BD Self Injection Device Product Portfolio
- 6.5.5 BD Recent Developments
- 6.6 Eli Lilly
- 6.6.1 Eli Lilly Company Information
- 6.6.2 Eli Lilly Business Overview
- 6.6.3 Eli Lilly Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Eli Lilly Self Injection Device Product Portfolio
- 6.6.5 Eli Lilly Recent Developments
- 6.7 Gerresheimer
- 6.7.1 Gerresheimer Company Information
- 6.7.2 Gerresheimer Business Overview
- 6.7.3 Gerresheimer Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Gerresheimer Self Injection Device Product Portfolio
- 6.7.5 Gerresheimer Recent Developments
- 6.8 Dongbao
- 6.8.1 Dongbao Company Information
- 6.8.2 Dongbao Business Overview
- 6.8.3 Dongbao Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Dongbao Self Injection Device Product Portfolio
- 6.8.5 Dongbao Recent Developments
- 6.9 Ypsomed
- 6.9.1 Ypsomed Company Information
- 6.9.2 Ypsomed Business Overview
- 6.9.3 Ypsomed Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Ypsomed Self Injection Device Product Portfolio
- 6.9.5 Ypsomed Recent Developments
- 6.10 Owen Mumford
- 6.10.1 Owen Mumford Company Information
- 6.10.2 Owen Mumford Business Overview
- 6.10.3 Owen Mumford Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Owen Mumford Self Injection Device Product Portfolio
- 6.10.5 Owen Mumford Recent Developments
- 6.11 Antares Pharma
- 6.11.1 Antares Pharma Company Information
- 6.11.2 Antares Pharma Business Overview
- 6.11.3 Antares Pharma Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Antares Pharma Self Injection Device Product Portfolio
- 6.11.5 Antares Pharma Recent Developments
- 6.12 Haselmeier
- 6.12.1 Haselmeier Company Information
- 6.12.2 Haselmeier Business Overview
- 6.12.3 Haselmeier Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Haselmeier Self Injection Device Product Portfolio
- 6.12.5 Haselmeier Recent Developments
7 North America by Country
- 7.1 North America Self Injection Device Sales by Country
- 7.1.1 North America Self Injection Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Self Injection Device Sales by Country (2021-2026)
- 7.1.3 North America Self Injection Device Sales Forecast by Country (2027-2032)
- 7.2 North America Self Injection Device Market Size by Country
- 7.2.1 North America Self Injection Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Self Injection Device Market Size by Country (2021-2026)
- 7.2.3 North America Self Injection Device Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Self Injection Device Sales by Country
- 8.1.1 Europe Self Injection Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Self Injection Device Sales by Country (2021-2026)
- 8.1.3 Europe Self Injection Device Sales Forecast by Country (2027-2032)
- 8.2 Europe Self Injection Device Market Size by Country
- 8.2.1 Europe Self Injection Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Self Injection Device Market Size by Country (2021-2026)
- 8.2.3 Europe Self Injection Device Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Self Injection Device Sales by Country
- 9.1.1 Asia-Pacific Self Injection Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Self Injection Device Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Self Injection Device Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Self Injection Device Market Size by Country
- 9.2.1 Asia-Pacific Self Injection Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Self Injection Device Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Self Injection Device Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Self Injection Device Sales by Country
- 10.1.1 South America Self Injection Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Self Injection Device Sales by Country (2021-2026)
- 10.1.3 South America Self Injection Device Sales Forecast by Country (2027-2032)
- 10.2 South America Self Injection Device Market Size by Country
- 10.2.1 South America Self Injection Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Self Injection Device Market Size by Country (2021-2026)
- 10.2.3 South America Self Injection Device Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Self Injection Device Sales by Country
- 11.1.1 Middle East and Africa Self Injection Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Self Injection Device Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Self Injection Device Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Self Injection Device Market Size by Country
- 11.2.1 Middle East and Africa Self Injection Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Self Injection Device Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Self Injection Device Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Self Injection Device Value Chain Analysis
- 12.1.1 Self Injection Device Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Self Injection Device Production Mode & Process
- 12.2 Self Injection Device Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Self Injection Device Distributors
- 12.2.3 Self Injection Device Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst